Kenvue
OrganizationHeard in 27 episodes across 4 shows since Sep 2025
Kenvue Inc. is an American consumer health company that was formerly the Consumer Healthcare division of Johnson & Johnson. It owns a portfolio of well-known global brands, including Aveeno, Band-Aid, Neutrogena, Listerine, and Tylenol.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 4 |
| Feb 2026 | 0 |
| Mar 2026 | 1 |
| Apr 2026 | 2 |
| May 2026 | 1 |
| Jun 2026 | 3 |
| Jul 2026 | 4 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 3 |
| Nov 2026 | 2 |
Email alert
Email me when Kenvue comes up on a podcast
One email a week at most, with the new episodes that mention Kenvue. Free, no account needed, unsubscribe in one click.
What experts have said about Kenvue
5 statements · 5 positive
Bryn says Kimberly-Clark’s Kenvue combination will produce $2 billion in synergies.
“They just combine with Kenview. So what happens is as that Kenview merger happens, they shove out $2 billion in synergies.”
Open the episode · The AI Bubble Already Popped with Jenny Harrington and Bryn TalkingtonListen at 1:02:53
Kenvue long-term shareholders should be fine despite lawsuits.
“I think the answer is no. I think you'll be fine.”
Open the episode · Mad Money w/ Jim Cramer 11/19/25Listen at 37:17
The Kimberly-Clark–Kenvue merger will create a leading global health and wellness company.
“This is really about two great, iconic American companies joining forces to what to create what we think is the preeminent. global health and wellness leader.”
Open the episode · Mad Money w/ Jim Cramer 11/3/25Listen at 11:02
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
27 episodes featuring Kenvue, newest first
- Nov 20, 2026
AI valuations meet public-market realityThe Compound and FriendsNov 20, 2026 - Nov 3, 2026
Cramer weighs tech’s sell-off against healthcare’s growth caseMad Money w/ Jim CramerNov 3, 2026 - Oct 31, 2026
Cramer weighs tech volatility against portfolio diversificationMad Money w/ Jim CramerOct 31, 2026 - Oct 30, 2026
AI spending fears drive a technology-led market sell-offCNBC's "Fast Money"Oct 30, 2026 - Oct 15, 2026
Cramer warns concentrated bets amplify market volatilityMad Money w/ Jim CramerOct 15, 2026 - Sep 22, 2026
Cramer argues portfolios should evolve with investors’ livesMad Money w/ Jim CramerSep 22, 2026